{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:07Z","timestamp":1762004227062},"reference-count":32,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1890,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr. Blood Cancer"],"published-print":{"date-parts":[[2010,12,1]]},"DOI":"10.1002\/pbc.22645","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T15:41:49Z","timestamp":1277826109000},"page":"1118-1125","source":"Crossref","is-referenced-by-count":16,"title":["Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy"],"prefix":"10.1002","volume":"55","author":[{"given":"Hirotoshi","family":"Sakaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoko","family":"Doisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"10.1002\/pbc.22645-BIB1|cit2","first-page":"5","article-title":"Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukaemia","volume":"55","author":"Jacobs","year":"1979","journal-title":"S Afr Med J"},{"key":"10.1002\/pbc.22645-BIB2|cit3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1002\/pbc.22645-BIB3|cit4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1002\/pbc.22645-BIB4|cit5","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1002\/pbc.22645-BIB5|cit6","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood"},{"key":"10.1002\/pbc.22645-BIB6|cit7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: Results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Hematol"},{"key":"10.1002\/pbc.22645-BIB7|cit8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): A retrospective multicenter study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB8|cit9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1700895","article-title":"Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: Retrospective analysis of 137 cases at a single institution","volume":"20","author":"Kami","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB9|cit10","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1002\/pbc.22645-BIB10|cit11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","article-title":"Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with haematologic malignancies: Incidence, onset time and risk factors","volume":"22","author":"Hasegawa","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB11|cit12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00043426-200212000-00013","article-title":"Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: Incidence, risk factors, and outcome in a cohort of 241 patients","volume":"24","author":"Reiss","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1002\/pbc.22645-BIB12|cit13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB13|cit14","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"10.1002\/pbc.22645-BIB14|cit15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","article-title":"Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation","volume":"40","author":"Cheuk","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB15|cit16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1002\/pbc.22645-BIB16|cit17","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1002\/pbc.22645-BIB17|cit18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1002\/pbc.22645-BIB18|cit19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bmt.1701172","article-title":"Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy","volume":"21","author":"Goringe","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB19|cit20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703226","article-title":"Oral eicosapentaenoic acid for complications of bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB20|cit21","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1002\/pbc.22645-BIB21|cit22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","article-title":"Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: A prospective phase II study","volume":"31","author":"Forrest","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB22|cit23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705696","article-title":"Prophylactic defibrotide in allogeneic stem cell transplantation: Minimal morbidity and zero mortality from veno-occlusive disease","volume":"40","author":"Dignan","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.22645-BIB23|cit24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0049-3848(82)90082-2","article-title":"A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal models","volume":"27","author":"Meuleman","year":"1982","journal-title":"Thromb Res"},{"key":"10.1002\/pbc.22645-BIB24|cit25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(87)90173-5","article-title":"Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke","volume":"1","author":"Turpie","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/pbc.22645-BIB25|cit26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19860801)58:3<761::AID-CNCR2820580325>3.0.CO;2-6","article-title":"Treatment of disseminated intravascular coagulation in acute promyelocytic leukemia with low molecular weight heparinoid Org 10172","volume":"58","author":"Nieuwenhuis","year":"1986","journal-title":"Cancer"},{"key":"10.1002\/pbc.22645-BIB26|cit27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(83)92107-4","article-title":"Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid","volume":"1","author":"Harenberg","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/pbc.22645-BIB27|cit28","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1002\/pbc.22645-BIB28|cit29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(83)91326-0","article-title":"Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complications","volume":"1","author":"Henny","year":"1983","journal-title":"Lancet"},{"key":"10.1002\/pbc.22645-BIB29|cit30","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2165\/00003495-200262150-00016","article-title":"Danaparoid: A review of its use in thromboembolic and coagulation disorders","volume":"62","author":"Ibbotson","year":"2002","journal-title":"Drugs"},{"key":"10.1002\/pbc.22645-BIB30|cit31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1160\/TH06-04-0226","article-title":"Danaparoid sodium reduces ischemia\/reperfusion-induced liver injury in rats by attenuating inflammatory responses","volume":"97","author":"Harada","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1002\/pbc.22645-BIB31|cit32","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/cc6943","article-title":"Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats","volume":"12","author":"Iba","year":"2008","journal-title":"Crit Care"},{"key":"10.1002\/pbc.22645-BIB32|cit33","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/cc6851","article-title":"Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats","volume":"12","author":"Hagiwara","year":"2008","journal-title":"Crit Care"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22645","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.22645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:13:39Z","timestamp":1625397219000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.22645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.22645","relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}